Document
type: Class

Academic Article
type: Class

Continuant
type: Class

Entity
type: Class

RDF description of Secukinumab Exhibits Sustained and Stable Response in Patients with Moderate-to-Severe Psoriasis: Results from the SUPREME Study - http://irises.unisr.it/resource/item/137083
rights: termsOfUse
date: 2026-08-26T09:01:53
publisher: Secukinumab Exhibits Sustained and Stable Response in Patients with Moderate-to-Severe Psoriasis: Results from the SUPREME Study
type: Document

Generically Dependent Continuant
type: Class

254269855
type: Entity
type: BFO_0000020
type: Authorship
type: Relationship
type: Continuant
type: Thing
relates: Secukinumab Exhibits Sustained and Stable Response in Patients with Moderate-to-Severe Psoriasis: Results from the SUPREME Study

Article
type: Class

Secukinumab Exhibits Sustained and Stable Response in Patients with Moderate-to-Severe Psoriasis: Results from the SUPREME Study
type: Entity
type: Information Content Entity
type: Document
type: Generically Dependent Continuant
type: Thing
language: Inglese
type: Article
type: Continuant
type: Academic Article
related by: 254269855
most specific type: Academic Article

Inglese
type: Language

Information Content Entity
type: Class